Tekin, Cansu http://orcid.org/0000-0003-3961-5603
Aberson, Hella L
Waasdorp, Cynthia
Hooijer, Gerrit K J
de Boer, Onno J
Dijk, Frederike
Bijlsma, Maarten F
Spek, C Arnold
Funding for this research was provided by:
KWF Kankerbestrijding (2014-6782)
Article History
Accepted: 7 July 2020
First Online: 18 August 2020
Compliance with ethical standards
:
: The authors declare that they have no competing interests. MFB has received research funding from Celgene and has acted as a consultant for Servier. These parties were not involved in the design or drafting of this manuscript.
: This research project used human tissues that were removed from patients during the course of treatment and that were later made available for scientific research (so-called ‘further use’ of human tissue). According to the Code of Conduct for dealing with responsibly for human tissues in the context of health research (Human Tissue and Medical Research: Code of conduct for responsible use drawn up by the Federation of Dutch Medical Scientific Societies in collaboration with the Dutch Patient Consumer federation, the Federation of Parent and Patient Organizations and the Biobanking and Biomolecular Resources Research Infrastructure; ExternalRef removed) these biological materials are as such, not subject to any requirement for ethical review or consent from patients.
: Not applicable.